Evaluation of aspirin use for primary prevention in diabetic patients
Ann Pharmacother
.
2015 Jan;49(1):150-1.
doi: 10.1177/1060028014561083.
Authors
Marta A Miyares
,
Kyle A Davis
PMID:
25524930
DOI:
10.1177/1060028014561083
No abstract available
Publication types
Letter
Comment
MeSH terms
Aspirin / therapeutic use*
Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Male
Platelet Aggregation Inhibitors / therapeutic use*
Substances
Platelet Aggregation Inhibitors
Aspirin